MedTrace Logo

Spectacle Independence and Overall Satisfaction With AcrySof® Panoptix® Toric Intraocular Lens

NCT04128514 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2022-04-01

No results posted yet for this study

Summary

The study was designed to assess the spectacle independence and satisfaction of patients receiving the AcrySof® Panoptix® Toric intraocular lens (IOL) after uneventful cataract surgery.

Conditions

  • Cataract

Interventions

DEVICE

Panoptix Toric

Cataract surgery and IOL implantation

Sponsors & Collaborators

  • Science in Vision

    collaborator OTHER

  • Eye Center of North Florida

    lead OTHER

Principal Investigators

  • Bret Fisher, MD · Eye Center of North Florida

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-11
Primary Completion
2022-03-10
Completion
2022-03-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04128514 on ClinicalTrials.gov